Available data in the literature regarding the differences in the investigated endpoints and elderly patients are scarce. Therefore, we performed a sample size calculation using data from the Hungarian Gastrointestinal Bleeding Registry collected between 2020 December and 2022. August.31 Post-hoc analysis of all patients who fit our current inclusion criteria and received oral iron at discharge (20 patients) resulted in a 20% occurrence for our primary outcome within 3 months. Reasons for mortality (20/3) and readmission (20/1) were related to ischaemic events. The assessed effect size is similar to already published data. A cohort analysis with elderly patients (>65 years) showed a 4.5% mortality rate for the whole population and a 32% 30-day readmission rate with anaemia. Considering that 28% of that cohort had malignancy and authors assessed all causes of readmission, a 15%–20% lower rate for unplanned rehospitalisation due to anaemia could be imagined if the iron stores are not replenished fast enough.32 Also, another study showed that when elderly patients are discharged with moderate or severe microcytic anaemia, the 3-month mortality rate can reach 8% (without excluding patients with cancer—22% of the cases).33
Based on the RCT of Bager et al, participants receiving intravenous iron had normalised Hb levels after 1 month. Data are lacking about the effect of intravenous iron on the investigated outcomes. However, results from other study populations found a 5% rate of anaemia-related events leading to hospitalisation only with intravenous iron34 35 and 0% mortality (two studies with small sample sizes).8 10 Due to unlimited data, we assumed that intravenous iron could result in at least a 50% risk decrease (to 10%) after non-variceal GIB since it could result in a quicker heamatopoiesis, preventing ischaemic events.10
With a 30% dropout rate,10 using a power of 80% and a significance level of 5% (two-sided χ2 test) to measure the treatment effect, we calculated a sample size of 570.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.